Dew if you are correct about the PPHM management intentions...then I quess we can expect really shabby results from their phase II HCV trial? Personally I do not know anything about their intentions. But it is my opinion that both Cotara and Bavi have produced some very good results against a variety of cancers. They are going after lung, liver and pancreatic cancers now. These are tough ones and I hope they do well. As for HCV...I am willing to wait for the results. I look forward to your assessment of those results. I hope we are pleasantly surprised. I must say that I have a lot more confidence in the company since Dr. Garnick(formerly of DNA) came on board. Regards,Dia.
Market Data 
Markets 
AI
